Drug Trial Radar · NCT06024642
Study of V117957 in Overactive Bladder Syndrome
Last checked: Nov 19, 2026Latest source record: Jun 26, 2025 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
51
Actual
Start
Jun 30, 2022
Primary completion
May 21, 2024
Study completion May 21, 2024
Sponsor
- Lead sponsor
- Imbrium TherapeuticsIndustry
- Sponsor type
- Industry
- Collaborators
- Purdue Pharma LP
- First posted
- Sep 6, 2023
Design
- Study type
- Interventional
- Phase
- Phase 1
- Allocation
- Randomized
- Model
- Crossover
- Masking
- Triple (participant, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- Female only, from 18 years, up to 70 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this study is to evaluate the safety, tolerability and efficacy of V117957 in subjects with overactive bladder syndrome, compared to placebo.
Conditions
- Overactive Bladder Syndrome
Interventions
V117957Drug
V117957 1 mg - 1 tablet taken orally at bedtime.
PlaceboDrug
Placebo to match V117957 tablets - 1 tablet taken orally at bedtime.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Change From Baseline in Micturition Episode Components (Micturition, Incontinence, and Urgency) Per 24 Hours.Time frame: Baseline, Weeks 2, and 8
Locations
12 sites in 1 country. Site status is shown where the registry gives one.
Arizona Urology Specialists, PLLC
Tucson, Arizona
Hope Clinical Research, LLC
Canoga Park, California
ARK Clinical Research
Long Beach, California
Urology Group of Southern California
Los Angeles, California
Providea Health Partners, LLC
Evergreen Park, Illinois
DelRicht Research
New Orleans, Louisiana
Ochsner LSU Health Shreveport - Regional Urology
Shreveport, Louisiana
Boston Clinical Trials
Boston, Massachusetts
Bay State Clinical Trials, Inc.
Watertown, Massachusetts
AccuMed Research Associates
Garden City, New York
Unified Women's Clinical Research-Lyndhurst
Winston-Salem, North Carolina
The Clinical Trial Center, LLC
Jenkintown, Pennsylvania
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.